• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Med . The SpO2/FiO2 Ratio Combined with Prognostic Scores for Pneumonia and COVID-19 Increases Their Accuracy in Predicting Mortality of COVI

tetano

Editor, Senior Moderator
J Clin Med


. 2024 Oct 2;13(19):5884.
doi: 10.3390/jcm13195884. The SpO[SUB]2[/SUB]/FiO[SUB]2[/SUB] Ratio Combined with Prognostic Scores for Pneumonia and COVID-19 Increases Their Accuracy in Predicting Mortality of COVID-19 Patients

Giuseppe Zinna[SUP] 1 2 [/SUP], Luca Pipitò[SUP] 2 [/SUP], Claudia Colomba[SUP] 2 3 [/SUP], Nicola Scichilone[SUP] 2 [/SUP], Anna Licata[SUP] 2 [/SUP], Mario Barbagallo[SUP] 2 [/SUP], Antonio Russo[SUP] 4 [/SUP], Nicola Coppola[SUP] 4 [/SUP], Antonio Cascio[SUP] 2 5 [/SUP]



Affiliations
Abstract

Background: Identifying high-risk COVID-19 patients is critical for emergency department decision-making. Our study's primary objective was to identify new independent predictors of mortality and their predictive utility in combination with traditional pneumonia risk assessment scores and new risk scores for COVID-19 developed during the pandemic. Methods: A retrospective study was performed in two Italian University Hospitals. A multivariable logistic model was used to locate independent parameters associated with mortality. Results: Age, PaO[SUB]2[/SUB]/FiO[SUB]2[/SUB], and SpO[SUB]2[/SUB]/FiO[SUB]2[/SUB] ratios were found to be independent parameters associated with mortality. This study found that the Pneumonia Severity Index (PSI) was superior to many of the risk scores developed during the pandemic, for example, the International Severe Acute Respiratory Infection Consortium Coronavirus Clinical Characterisation Consortium (ISARIC 4C) (AUC 0.845 vs. 0.687, p < 0.001), and to many of the risk scores already in use, for example, the National Early Warning Score 2 (NEWS2) (AUC 0.845 vs. 0.589, p < 0.001). Furthermore, our study found that the Pneumonia Severity Index had a similar performance to other risk scores, such as CRB-65 (AUC 0.845 vs. 0.823, p = 0.294). Combining the PaO[SUB]2[/SUB]/FiO[SUB]2[/SUB] or SpO[SUB]2[/SUB]/FiO[SUB]2[/SUB] ratios with the risk scores analyzed improved the prognostic accuracy. Conclusions: Adding the SpO[SUB]2[/SUB]/FiO[SUB]2[/SUB] ratio to the traditional, validated, and already internationally known pre-pandemic prognostic scores seems to be a valid and rapid alternative to the need for developing new prognostic scores. Future research should focus on integrating these markers into existing pneumonia scores to improve their prognostic accuracy.

Keywords: COVID-19; CRB-65; CZ COVID-19; PSI; PaO2/FiO2 ratio; SpO2; SpO2/FiO2 ratio; prognostic score; risk score.

 
Back
Top Bottom